|
|
|
By Carl Accettura, Global Pharma Advisory | A June meeting showed industry is struggling to meet the DSCSA's November deadline. Eligible companies might find relief in an FDA waivers and exemptions program. |
|
|
|
|
| Direct-To-Patient RTSM Solution | White Paper | By Bart Nicholson, Signant Health | Since the late 1990s, IRT has been central to clinical supply management. Modern DCTs now bring the supply chain into the patient experience. Let's explore direct-to-patient models and their pros and cons. |
|
|
|
|
|
|
.png){kind=logo}
